Blood Cancer Journal (Aug 2023)
Comparison of tisagenlecleucel with conventional treatments for relapsed/refractory diffuse large B-cell lymphomas: a retrospective external comparator study
Abstract
No abstracts available.
Blood Cancer Journal (Aug 2023)